Nancy L. Snyderman, M.D.

Nancy L. Snyderman, M.D.

DirectoratAlkermes plc.· In proxies 2023–2025

Nancy L. Snyderman, M.D. sits on 5 public boards.

Boards1

  • Alkermes plc.Director · 7 yr on the boardIndependentBinding Authorization of Audit and Risk, Compensation, Nominating and Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Alkermes plc.Public company · 3 yr
    • Director2023 – Present · 3 yrStock in role +80%
  2. Axonics, Inc. (Nasdaq: AXNX) since April 2019 Lyra Therapeutics, Inc. (Nasdaq: LYRA) since October 2020Public company
    • Director? – PresentNo stock prices for these years
  3. Lyra Therapeutics, Inc. (Nasdaq: LYRA) since October 2020Public company
    • Director? – PresentNo stock prices for these years
  4. Future Health ESG Corp.Public company · 3 yr
    • Director2021 – 2024 · 3 yrNo stock prices for these years
  5. Axonics, Inc.Public company · 5 yr
    • Director2019 – 2024 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?